Private Equity Firm Frazier Healthcare Partners Picks Up RevSpring

Private Equity Firm Frazier Healthcare Partners Picks Up RevSpring

Healthcare-focused private equity firm Frazier Healthcare Partners announced on March 12 the completion of its acquisition of RevSpring from Chicago, Illinois-based GTCR. Frazier is joined in the transaction by NEA, 22C Capital and RevSpring’s senior leadership team.  RevSpring offers physical and electronic invoices, consumer payment portals, data cleansing solutions and analytics tools. It serves a client base of approximately 2,000 health systems and hospitals, revenue cycle management (RCM) providers and financial services organizations. The company was originally acquired by GTCR in November 2016.  Frazier Healthcare Partners is a provider of growth capital to healthcare... Read More »
PE-Backed Elevate Patient Financial Solutions Acquires Professional Medical Services

PE-Backed Elevate Patient Financial Solutions Acquires Professional Medical Services

Elevate Patient Financial Solutions, backed by private equity firms Frazier Healthcare Partners and The Edgewater Funds, announced on January 9 the acquisition of Professional Medical Services.  Professional Medical Services is a provider of revenue cycle management (RCM) solutions focused on low-balance accounts receivable resolution. The company was founded in 1991 and is based in Fort Worth, Texas.  Elevate Patient Financial Solutions delivers RCM solutions to hospitals, health systems and health providers nationwide.  The acquisition will expand Elevate’s suite of RCM solutions and reinforce its commitment to addressing the most complex aspects of the revenue cycle for... Read More »
Adare Pharmaceuticals Sold to Two Private Equity Firms

Adare Pharmaceuticals Sold to Two Private Equity Firms

Two private equity firms, Thomas H. Lee Partners and Frazier Healthcare Partners, are teaming up to acquire a leading specialty contract development and manufacturing organization (CDMO). The firms are buying Adare Pharmaceuticals. a global provider of advanced pharmaceutical technologies, development and manufacturing. The company utilizes its differentiated pharmaceutical technology and microbiome scientific platforms to develop novel, improved medicines and therapies for the global market. Adare has developed and manufactured more than 40 products sold by partners in more than 100 countries globally including Lacteol, Zoolac, Viactiv, and a number of branded and complex generic... Read More »
Mednax Sells MedData, Pulls Back on M&A

Mednax Sells MedData, Pulls Back on M&A

It’s been nearly a year since Mednax Inc. (NYSE: MD) announced its MedData subsidiary was headed for the auction block. The company acquired the privately held revenue cycle management company in August 2014 for an undisclosed amount. Now that Mednax has hired teams of consultants to help it rethink its business model, MedData is a non-core asset. Frazier Healthcare Partners agreed to pay $250 million for MedData in mid-October, although Mednax has classified MedData as discontinued operations since the first quarter of 2019. The target provides management services to hospitals, health systems and healthcare providers. Back in 2014, when Mednax bought it, MedData served 3,000 physicians at... Read More »
U.S. Renal Care Gets Big New Backers

U.S. Renal Care Gets Big New Backers

U.S. Renal Care has new owners, as of February 13. It marks the first renal-related transaction in 2019 and it won’t be the last. The national dialysis provider was backed by a consortium of private equity firms such as Leonard Green & Partners, Frazier Healthcare Partners, New Enterprise Associates and Cressey & Company. Stepping in to take over is Bain Capital Private Equity, Summit Partners and Revelstoke Partners, with participation by the company’s executive management team. Financial terms were not disclosed, naturally. U.S. Renal Care works with nephrologists to develop, acquire and operate outpatient treatment centers for people suffering from chronic kidney... Read More »